Geron Corp (0IV3)
LSE
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current 0IV3 market cap is 2.19B. The company's latest EPS is USD -0.2888 and P/E is -5.71.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 253k | 1.39M | 596k | 237k | 76.99M |
| Operating Income | -76.91M | -114M | -138.55M | -193.94M | -173.73M |
| Net Income | -75.62M | -116.11M | -141.9M | -184.13M | -174.57M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 270.73M | 226.03M | 190.58M | 394.08M | 593.78M |
| Total Liabilities | 59.78M | 99.62M | 110.58M | 146.13M | 313.46M |
| Total Equity | 210.95M | 126.42M | 80M | 247.95M | 280.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -66.65M | -95.56M | -127.38M | -167.74M | -218.62M |
| Investing | -105.32M | 71.95M | 62.07M | -180.32M | -106M |
| Financing | 168.35M | 48.56M | 87.26M | 362.02M | 334.37M |
| Market Cap | 2.19B |
| Price to Earnings Ratio | -5.71 |
| Price to Sales Ratio | 12.95 |
| Price to Cash Ratio | 12.62 |
| Price to Book Ratio | 3.56 |
| Dividend Yield | - |
| Shares Outstanding | 604.5M |
| Average Volume (1 week) | 16.73k |
| Average Volume (1 Month) | 26.98k |
| 52 Week Change | 0.00% |
| 52 Week High | 3.63 |
| 52 Week Low | 3.63 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Geron Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.geron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
